Tailored Care for Patients With Possible Pneumonia Who Test Positive for Respiratory Viruses
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
To the Editor—We welcome the opportunity to respond to questions regarding our paper analyzing associations between antibiotic use and outcomes for patients with possible pneumonia who test positive for respiratory viruses [1]. We value scientific debate, but we regret that most of the points raised in the letter misstated our methods, findings, and conclusions [2]. The letter stated: Quite the reverse. Table 2 shows that 2057/6779 (30.3%) of our overall cohort received 0 days of antibiotics and eTable 4 shows that 1190/1720 (69.2%) of patients treated for 0–2 days in the primary analysis received 0 days of antibiotics. In addition, we conducted a sensitivity analysis comparing propensity-weighted outcomes between the 1190 patients treated with 0 days of antibiotics and 894 patients treated with 5–7 days of antibiotics (Figure 2 and eTable 4). We found no significant differences between these groups in hospital length of stay (11.9 vs 11.1 days, adjusted odds ratio [aOR] 1.07, 95% CI .98–1.18), ICU admissions after 48 hours (28.2% vs 27.9%, aOR 1.02, 95% CI .82–1.25), in-hospital mortality (9.0% vs 10.1%, aOR 0.89, 95% CI .60–1.31), or 30-day hospital-free days alive (16.8 vs 17.1, aOR 0.98, 95% CI .93–1.03).
Fields of Study & Subjects
Pneumonia and Respiratory Infections
Antibiotic Use and Resistance
Respiratory viral infections research
Publication details
- Journal / source
- Clinical Infectious Diseases
- Volume
- 83
- Issue
- 2
- Pages
- e448–e449
- Publication date
- 25 March 2026
- Language
- EN